NIDAN — Nidan Laboratories and Healthcare Balance Sheet
0.000.00%
- IN₹298.85m
- IN₹390.96m
- IN₹245.28m
- 69
- 75
- 17
- 56
Annual balance sheet for Nidan Laboratories and Healthcare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
R2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 73 | 81 | 84.2 | 28.5 | 19 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 54.3 | 59.2 | 93.9 | 245 | 55.9 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 229 | 243 | 209 | 303 | 112 |
Net Property, Plant And Equipment | 201 | 243 | 214 | 180 | 165 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 537 | 885 | 844 | 826 | 829 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 262 | 128 | 95.4 | 113 | 102 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 404 | 226 | 150 | 163 | 148 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 133 | 659 | 694 | 662 | 682 |
Total Liabilities & Shareholders' Equity | 537 | 885 | 844 | 826 | 829 |
Total Common Shares Outstanding |